These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5374943)

  • 21. Interactions of monoamine oxidase inhibition and sympathomimetic amines on the human iris.
    Bevan-Jones B; Lind NA
    Br J Pharmacol; 1971 Feb; 41(2):428P-429P. PubMed ID: 5572317
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the mechanism of the hypotensive action of monoaminoxidase inhibitors].
    Gawecka I; Gumulka W
    Acta Physiol Pol; 1965; 16(4):567-77. PubMed ID: 4223825
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction between tyramine and iproniazid on guinea-pig atria.
    Garcia de Jalón PD; Martinez-Sierra R; Velasco A
    Br J Pharmacol; 1973 Aug; 48(4):609-11. PubMed ID: 4788204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of reversal of the blood pressure by ephedrine. (2)].
    Saito H
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):83-92. PubMed ID: 558948
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
    Provost JC; Funck-Brentano C; Rovei V; D'Estanque J; Ego D; Jaillon P
    Clin Pharmacol Ther; 1992 Oct; 52(4):384-93. PubMed ID: 1424410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.
    Lader MH; Sakalis G; Tansella M
    Psychopharmacologia; 1970 Aug; 18(1):118-23. PubMed ID: 4943186
    [No Abstract]   [Full Text] [Related]  

  • 30. A selective, reversible, competitive inhibitor of monoamine oxidase A containing no nitrogen, with negligible potentiation of tyramine-induced blood pressure rise.
    Harfenist M; McGee DP; White HL
    J Med Chem; 1991 Sep; 34(9):2931-3. PubMed ID: 1895310
    [No Abstract]   [Full Text] [Related]  

  • 31. [Noradrenaline liberating activity of orally administered tyramine and its potentiation by MAO inhibitors].
    Spano PF
    Boll Soc Ital Biol Sper; 1966 Oct; 42(20):1452-5. PubMed ID: 5972404
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction between some cheeses and monoamine oxydase inhibitors.
    Kayaalp SO; Kaymakçalan S; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1195-8. PubMed ID: 5756049
    [No Abstract]   [Full Text] [Related]  

  • 33. Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats.
    Naruganahalli KS; Shirumalla RK; Bansal V; Gupta JB; Das B; Ray A
    Eur J Pharmacol; 2006 Sep; 545(2-3):167-72. PubMed ID: 16899241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between phenylpropanolamine and monoamine oxidase inhibitors.
    D'Mello A
    J Pharm Pharmacol; 1969 Sep; 21(9):577-80. PubMed ID: 4390334
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of phenyl-alkyl hydrazines on the blood pressure in the cat].
    Lössner B; Matthies H
    Acta Biol Med Ger; 1971; 27(5):971-82. PubMed ID: 5148780
    [No Abstract]   [Full Text] [Related]  

  • 36. The blockade of the pressor response to tyramine by amphetamine in the reserpine-treated dog.
    Eble JN; Rudzik AD
    J Pharmacol Exp Ther; 1966 Jul; 153(1):62-9. PubMed ID: 5921358
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between histamine and monoamine oxidase inhibitors.
    Allen GS; Rand MJ
    J Pharm Pharmacol; 1969 May; 21(5):317-22. PubMed ID: 4390125
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of L-ascorbic acid in the reversal of the monoamine oxidase inhibition by caffeine.
    Glazigna L; Maina G; Rumney G
    J Pharm Pharmacol; 1971 Apr; 23(4):303-5. PubMed ID: 4396911
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the pharmacological action spectrum of some new hydrazine derivatives].
    Fermum R
    Acta Biol Med Ger; 1966; 16(2):169-77. PubMed ID: 5982348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.